David Navarro
University of Valencia
Internal medicineAntigenVirologyAntibodyCD8ImmunologyVirusHematopoietic stem cell transplantationCongenital cytomegalovirus infectionStem cellTransplantationSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Coronavirus disease 2019 (COVID-19)In patientIncidence (epidemiology)Real-time polymerase chain reactionMedicineBiologyMicrobiologyGastroenterology
270Publications
30H-index
3,059Citations
Publications 267
Newest
#2David Navarro (University of Valencia)H-Index: 30
Last. Mario Fernández-Ruiz (Complutense University of Madrid)H-Index: 37
view all 4 authors...
The immune system plays a key role in the host defense against viral pathogens. A signaling cascade is activated upon infection involving a variety of molecules such as pattern-recognition receptors (PRRs), interleukins or antiviral interferons. Long-term immunosuppression after solid organ transplantation (SOT) mainly abrogates adaptive T-cell-mediated responses, thus highlighting the relative contribution of innate immunity. Single-nucleotide polymorphisms (SNPs) within genes coding for PRRs o...
Source
#1Beatriz OleaH-Index: 5
#2Eliseo AlbertH-Index: 13
Last. Jesús Rodríguez-Díaz (University of Valencia)H-Index: 23
view all 12 authors...
The current study aimed at characterizing the dynamics of SARS-CoV-2 nucleocapsid (N) antigenemia in a cohort of critically ill adult COVID-19 patients and assessing its potential association with plasma levels of biomarkers of clinical severity and mortality. Seventy-three consecutive critically ill COVID-19 patients (median age, 65 years) were recruited. Serial plasma (n = 340) specimens were collected. A lateral flow immunochromatography assay and reverse-transcription polymerase chain reacti...
Source
#1José Luis Piñana (University of Valencia)H-Index: 22
Last. Anna SuredaH-Index: 71
view all 33 authors...
This is a multicenter prospective observational study which included a large cohort (n = 397) of allogeneic (allo-HSCT) (n = 311) and autologous (ASCT) hematopoietic stem cell transplant (n = 86) recipients who were monitored for antibody detection within 3 to 6 weeks after complete SARS-CoV-2 vaccination from February 1st 2021 to July 20th 2021. Most patients (n = 387, 97.4%) received mRNA-based vaccines. Most of recipients (93%) were vaccinated more than 1 year after transplant. Detectable SAR...
Source
Abstract null null Kidney disease is frequent in HIV-patients. We present a case of a 44-year-old woman, with known uncontrolled HIV infection and chronic kidney disease due to HIV-associated nephropathy. After starting dolutegravir, the patient developed eosinophilia and worsening kidney function. A kidney biopsy confirmed the diagnosis of acute interstitial nephritis. Given the time relation with dolutegravir introduction, it was deemed the culprit medication. Dolutegravir was stopped, and cor...
Source
#1José Luis PiñanaH-Index: 22
#2Lourdes VázquezH-Index: 34
Last. Francesc BoschH-Index: 66
view all 31 authors...
In the midst of the COVID-19 pandemic, different vaccines in front of SARS-CoV-2 have been approved and administered in different vulnerable populations. As patients with cancer were excluded from pivotal trials of vaccination, little is known on their immunogenic response to these vaccines, particularly in patients with severely impaired immune system. In response to that uncertainty, the Spanish Society of Hematology and Hemotherapy launched an initiative aimed to provide recommendations for v...
Source
#1Beatriz Sánchez-Sendra (University of Valencia)H-Index: 3
#2Eliseo AlbertH-Index: 13
Last. David Navarro (University of Valencia)H-Index: 30
view all 10 authors...
ABSTRACT null Immunosenescence may impact the functionality and breadth of vaccine-elicited humoral immune responses. The ability of sera to neutralize the SARS-CoV-2 spike protein (S) from Beta, Gamma, Delta, and Epsilon variants of concern (VOCs) relative to the ancestral Wuhan-Hu-1 strain was compared in Comirnaty® COVID-19-vaccinated elderly nursing home residents (n=30) or younger individuals (n=18) and non-vaccinated individuals who recovered from severe COVID-19 (n=19). In all groups, som...
Source
#1Eliseo AlbertH-Index: 13
Last. David Navarro (University of Valencia)H-Index: 8
view all 27 authors...
Abstract null null Objectives null The current study was aimed at examining SARS-CoV-2 immune responses following two doses of Comirnaty® COVID-19 vaccine among elderly people in nursing homes. null null null Methods null A prospective cohort study in a representative sample from nursing homes in Valencia (n = 881; males: 271, females 610; median age, 86 years) recruited residents using a random one-stage cluster sampling approach. A lateral flow immunochromatography device (LFIC) (OnSite COVID-...
Source
#1Patrícia AlvesH-Index: 17
#2David NavarroH-Index: 30
Last. Fernando NolascoH-Index: 10
view all 5 authors...
Source
The coronavirus disease 2019 (COVID-19) pandemic has affected the world radically since 2020. Spain was one of the European countries with the highest incidence during the first wave. As a part of a consortium to monitor and study the evolution of the epidemic, we sequenced 2,170 samples, diagnosed mostly before lockdown measures. Here, we identified at least 500 introductions from multiple international sources and documented the early rise of two dominant Spanish epidemic clades (SECs), probab...
Source
#1Enric Cuevas-Ferrando (CSIC: Spanish National Research Council)H-Index: 7
#2Walter Randazzo (CSIC: Spanish National Research Council)H-Index: 22
Last. Gloria Sánchez (CSIC: Spanish National Research Council)H-Index: 29
view all 10 authors...
Isolation, contact tracing and restrictions on social movement are being globally implemented to prevent and control onward spread of SARS-CoV-2, even though the infection risk modelled on RNA detection by RT-qPCR remains biased as viral shedding and infectivity are not discerned. Thus, we aimed to develop a rapid viability RT-qPCR procedure to infer SARS-CoV-2 infectivity in clinical specimens and environmental samples. We screened monoazide dyes and platinum compounds as viability molecular ma...
Source
This website uses cookies.
We use cookies to improve your online experience. By continuing to use our website we assume you agree to the placement of these cookies.
To learn more, you can find in our Privacy Policy.